Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
gene, leading to methylation of the promoter and gene silencing. The fragile X premutation, characterized by a 55 to 200 CGG repeat expansion, causes health problems and developmental difficulties in some, but not all, carriers. The premutation causes primary ovarian insufficiency in approximately 20% of females, psychiatric problems (including depression and/or anxiety) in approximately 50% of carriers and a neurodegenerative disorder, the fragile X-associated tremor ataxia syndrome (FXTAS), in approximately 40% of males and 16% of females later in life. Recent clinical studies in premutation carriers have expanded the health problems that may be seen. Advances in the molecular pathogenesis of the premutation have shown significant mitochondrial dysfunction and oxidative stress in neurons which may be amenable to treatment. Here we review the clinical problems of carriers and treatment recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mindfulness-based stress reduction and health benefits
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00573-7 · Cited by 3,958
Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496
Mindfulness-based stress reduction and health benefits: A meta-analysis
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2003) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2003.tb04008.x · Cited by 1,394 · cited 1×
“meditation has been shown to reduce anxiety, improve mood, and increase brain GABA levels [205].”
BackgroundRecovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227 · cited 2×
“The phenotype of these individuals is somewhat different from typically affected males with FXS because a mild deficit of FMRP usually causes only mild developmental problems so that these individuals have a higher IQ, and less severe behavioral problems than those with full mutation FXS [36,61,66-68].”
BackgroundEffects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · cited 3×
“Substance Outcome Study Population Reference Alpha Tocopherol Normalization of synaptic FMR1 KO Mouse [165] (Vitamin E) connections Improvements in dementia Alzheimer disease [166,167] Reduction of oxidative stress FMR1 KO Mouse [165] Melatonin Glutathione level FMR1 KO Mouse [168] normalization Improvement of anxiety…”
BackgroundResultAdult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813 · cited 2×
“This combination reduces brain atrophy in typically aging individuals and also in those with mild cognitive impairment (MCI) [175].”
BackgroundShort- and long-term benefits of cognitive training
Jaeggi, S. M., Buschkuehl, M., Jonides, J., & Shah, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103228108 · Cited by 769
Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., et al. (2014) · JAMA · doi:10.1001/jama.2013.282834 · Cited by 628
Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage
Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A. M., Sanchez-Vera, I., & Guerri, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0976-10.2010 · Cited by 579 · cited 1×
“Chronic excessive alcohol consumption can cause neuroinflammation, brain damage, and disrupts myelination [153,154].”
Background
Cited by
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Self-citationFragile X-associated tremor/ataxia syndrome — features, mechanisms and management
Hagerman, R. J., & Hagerman, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.82 · Cited by 290
Self-citationFragile X-Associated Neuropsychiatric Disorders (FXAND)
Hagerman, R. J., Protic, D., Rajaratnam, A., Salcedo-Arellano, M. J., Aydin, E. Y., & Schneider, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00564 · Cited by 204
Self-citationFragile X–associated tremor/ataxia syndrome
Hagerman, P. J., & Hagerman, R. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12693 · Cited by 172
Self-citationWheeler, A. C., Miller, S., Wylie, A., & Edwards, A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00316 · Cited by 15
“Because of this growing concern, researchers and clinicians are publicly calling for innovative, empirically based stress reduction interventions for this population (21).”
Background
Metadata
- Authors
- Hagerman, R.
- Venue
- Brain Disorders & Therapy
- Publisher
- OMICS Publishing Group
- Published
- 2014
- Volume
- 03
- Issue
- 02
- ISSN
- 2168-975X (ISSN-L)
- OpenAlex
- W2121716807
- Cited by
- 53
- References
- 40
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. https://app.cochat.ai/papers/10.4172/2168-975x.1000119
- The paper
- Hagerman, R. (2014). Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disorders & Therapy. https://doi.org/10.4172/2168-975x.1000119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.